Biases in the Parsortix system observed with pancreatic cancer cell lines
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen Claes
This study evaluates the Parsortix system's bias in capturing pancreatic cancer cells with different epithelial-mesenchymal transition (EMT) phenotypes, finding lower recovery rates for mesenchymal-like cells.
Molecular Oncology · Jun 18, 2025Peer-reviewedCancer Biology